Introduction
Glucocorticoid-induced apoptosis plays an important physiological role, contributing to maintenance of homeostasis in the immune system (Ashwell et al., 2000; Jondal et al., 2004) . As their ability to induce apoptosis in immature lymphocytes, glucocorticoids (dexamethasone, prednisone) are among the most effective agents for treatment of lymphoid malignancies (Schmidt et al., 2004) . However, their therapeutic use is limited because of the development of glucocorticoid resistance by lymphoma and leukemia cells. An improved understanding of the fundamental mechanism of glucocorticoid-induced apoptosis will provide the means to decipher mechanisms of glucocorticoid resistance and to discover new therapeutic targets for use in treatment of lymphoid malignancies.
Glucocorticoids suppress lymphocyte proliferation and survival by two fundamental processes. First, glucocorticoids arrest proliferating lymphocytes in G 1 phase of the cell cycle (Harmon et al., 1979) . Second, glucocorticoids induce apoptosis (Wyllie, 1980) . Glucocorticoids initiate their biological function by binding to the ubiquitously expressed and cytoplasmically located glucocorticoid receptor. The ligand/receptor complex enters the nucleus where it binds to glucocorticoid response elements (GREs) in a dimeric state to activate or repress transcription of corresponding genes. This process requires de novo RNA/protein synthesis (Cohen and Duke, 1984; Wyllie et al., 1984) . The transactivation activity of the glucocorticoid receptor appears essential for thymocyte apoptosis (Dieken and Miesfeld, 1992; Chapman et al., 1996; Ramdas and Harmon, 1998) and thymocytes from mice carrying a point mutation in one of the dimerization domains fail to undergo apoptosis in response to glucocorticoid treatment (Reichardt et al., 1998) . Moreover, the trans-repression activity of the glucocorticoid receptor may also contribute to glucocorticoid-induced apoptosis (Helmberg et al., 1995; Thompson, 1998) . However, the identity of the target genes whose trans-activation or trans-repression initiates glucocorticoid-induced apoptosis has been elusive.
We have used oligonucleotide microarrays to identify glucocorticoid-regulated genes in three separate but related model systems: the S49.A2 and WEHI7.2 murine T-cell lymphoma lines, and primary murine thymocytes (Wang et al., 2003a, b; Malone et al., 2004) . Dexamethasone (Dex) induces apoptosis in all three systems, although with different kinetics. Primary thymocytes undergo apoptosis within 8-12 h of exposure to Dex, whereas in S49.A2 and WEHI7.2 cells apoptosis is delayed for over 24 h (Wang et al., 2003a, b) . Through oligonucleotide microarray analysis, we have identified three apoptosis-related genes induced by Dex in all three model systems: bim, dig2, and tdag8 (Wang et al., 2003a, b; Malone et al., 2004) . Now, in the present study, which is also based on microarray findings, we show that the gene encoding thioredoxin-interacting protein (TXNIP), a natural inhibitor of the antioxidant protein thioredoxin, is rapidly induced by Dex in each of the model systems. This induction is rapid and mediated by a GRE in the gene promoter. The induction of txnip by Dex is intriguing because of extensive evidence that an alteration in redox state contributes to Dex-induced apoptosis (Tome et al., 2001; Tonomura et al., 2003) . In this regard, we show that expression of a GFP-TXNIP fusion protein is sufficient to induce apoptosis in WEHI7.2 cells and that repression of txnip expression by RNA interference significantly inhibits Dex-induced apoptosis. These findings indicate that txnip is a novel glucocorticoid receptor transcriptional target involved in mediating Dex-induced apoptosis.
Results

Microarray analysis
Oligonucleotide microarray analysis was employed to identify glucocorticoid-regulated genes that are potentially involved in mediating or regulating glucocorticoidinduced apoptosis in two murine T-cell lymphoma cell lines, S49.A2 and WEHI7.2 as well as in primary murine thymocytes. Dex, a synthetic glucocorticoid, induces apoptosis in all three model systems, as reported previously (Wang et al., 2003a, b) . The gene expression profiles of the S49.A2 and WEHI7.2 lines and of primary murine thymocytes treated with or without 1 mM Dex from 2 to 24 h were determined using Affymetrix GeneChips. There are 12 500 genes or expressed sequenced tags represented on the arrays employed in these experiments. Affymetrix reported that probes for 2611 genes or expressed sequenced tags were defective on the early batch of MG-U74A(v2) GeneChips which we had used for the expression profiles of the S49.A2 cell line. However, these 2611 defective probes were corrected in the GeneChips, which we used subsequently for the expression profiles of WEHI7.2 cells and primary thymocytes. Since we initially sought to identify Dex-regulated genes common to all three model systems, we excluded from our initial analysis the 2611 genes or expressed sequence tags corresponding to defective probes. By this analysis, seven genes were coordinately regulated by Dex in S49.A2, WEHI7.2, and primary thymocytes (Figure 1a) . We found that three of these genes (dig2, bim, and tdag8) have important roles in Dex-induced apoptosis (Wang et al., 2003a, b; Malone et al., 2004) . From the 2611 genes or expressed sequenced tags excluded from this initial analysis, we sought to identify additional Dex-regulated genes common to two model systems, WEHI7.2 cells and primary murine thymocytes, using arrays in which the defective probes had been corrected by Affymetrix. The expression of a total of 55 genes in WEHI7.2 and 11 genes in primary thymocytes were changed significantly. Five genes were similarly regulated by Dex in both WEHI7.2 cells and the primary thymocytes (Figure 1b) . Only one of them, T-cell death associated gene 51 was downregulated by Dex. It has been suggested this gene may be associated with Fas and T-cell receptor activation-induced apoptosis although its functional role is not entirely clear (Park et al., 1996; Qian et al., 1997; Wang et al., 1998; Rho et al., 2001; Oberg et al., 2004) . Of the other four Dex-induced genes, one encodes alpha mannosidase 1, one encodes TXNIP, and two are ESTs. The most prominently induced gene within this group of five was txnip, which was induced B3-4-fold at every time point analysed after Dex treatment (Figure 1c and d). As the strength of its induction and its predicted function in redox regulation, txnip was selected for further investigation.
Induction of txnip mRNA by Dex
The induction of txnip was confirmed by Northern blot analysis of RNA from Dex-treated WEHI7.2 cells (Figure 2a ) and primary thymocytes (Figure 2b ). In txnip induction by dexamethasone Z Wang et al the WEHI7.2 cell line, txnip mRNA levels were elevated by 3 h and reached maximum expression levels by 24 h (Figure 2a ). In primary thymocytes txnip was induced to maximal levels of expression within 2-4 h after Dex treatment (Figure 2b ). In the S49.A2 cells, txnip was also induced by 3 h and progressively accumulated throughout the subsequent 36 h time course (Figure 2c ). In the human acute T-cell leukemia CEM-C7 cells, txnip was also induced as early as 12 h after Dex treatment ( Figure 2d ). Thus, Dex induces txnip expression in both murine and human T cells.
Induction of txnip requires transcriptional activation mediated through the glucocorticoid receptor The rapid induction of txnip by Dex suggested a primary transcriptional response. Therefore, the role of glucocorticoid receptor-mediated transcription in the induction of txnip by Dex was tested in both S49.A2 and WEHI7.2 murine T-cell lines using either actinomycin D to inhibit transcription or RU486 to block glucocorticoid receptor activation by Dex. The findings were essentially the same in both cell lines, so examples of each experimental approach are illustrated in each of the two cell lines in Figure 3 . As shown in Figure 3a , actinomycin D treatment inhibited txnip mRNA induction by Dex, suggesting that the induction of txnip by Dex is indeed transcriptionally controlled.
Txnip mRNA appears to have a relatively short half-life because the abundance of txnip mRNA reduced to nearly undetectable levels from 3 to 12 h after actinomycin D treatment. The effect of cycloheximide treatment on txnip mRNA induction was tested as a means of determining whether or not txnip induction was a primary response to Dex or alternatively was secondary to induction of another gene. However, txnip mRNA was super-induced by Dex in the presence of cycloheximide ( Figure 3a ). The significance of this observation is unknown, but one possible explanation is the existence of a short-lived inhibitor of txnip transcription that is effectively reduced by cycloheximide treatment. To test the involvement of the glucocorticoid receptor in txnip induction, WEHI7.2 cells were cultured in the presence of 1 mM of Dex and/or a 10-fold excess of the glucocorticoid receptor antagonist RU486. RU486 prevented the induction of txnip mRNA by Dex in WEHI7.2 cells (Figure 3b ) indicating that the induction of txnip mRNA expression by Dex requires glucocorticoid receptor activation.
Cloning and characterization of the murine txnip promoter To investigate the mechanism by which Dex induces the expression of txnip mRNA, we amplified the murine txnip promoter region 1081 base pairs upstream from and 27 base pairs downstream from the transcription start site by PCR using genomic DNA as the template. To confirm that the amplified txnip promoter region has promoter activity, the obtained sequence was cloned into a promoter-less pGL3B luciferase reporter vector to generate the reporter construct pGL3B-1081 and luciferase reporter assays were performed. Transfection of pGL3B-1081 into WEHI7.2 cells in the absence of Dex yielded basal reporter gene activity that was greater than the activity of a SV40 positive control promoter (pGL3P), while transfection with pGL3B vector yielded barely detectable reporter gene activity ( Figure 4a ). This indicates that the cloned txnip promoter is functional.
To test whether Dex induces the activity of the cloned txnip promoter, WEHI7.2 cells were transfected with the reporter constructs, pGL3B or pGL3B-1081, and after a 4 h delay treated with or without 10-1000 nM Dex for 12 h. The activity of the txnip promoter construct pGL3B-1081 was induced in a dose-dependent manner by Dex, whereas the activity of pGL3B was only slightly induced by Dex (Figure 4b ). To determine the promoter region(s) important for Dex-induced txnip gene expression, a series of deletion constructs were generated by PCR (Figure 5a ). Transient transfection assays in the absence of Dex treatment indicated that strong basal promoter activity is detected with the construct pGL3B-148 containing the region from À148 to þ 47. The strong promoter activity is further increased when the promoter region between À148 and À417 is included in the construct pGL3B-417 or the promoter region between À514 and À764 is included in the construct pGL3B-764. This suggests the presence of the transcriptional activator binding sites in those regions. In contrast, the basal promoter activity decreases when the promoter region between À764 and À940 is included, suggesting that there may be a repressor function within the region À940 to À764 (Figure 5b ). Addition of 1 mM Dex for 12 h to transfected cells caused the induction of luciferase activity by 2.8-and 5.8-fold for promoter constructs pGL3B-940 and pGL3B-1081 respectively, while deletions beyond À764 resulted in less than twofold induction of luciferase activity by Dex (Figure 5c ). Thus, the apparent repressor of basal transcription activity assigned to the region À940 to À764 is overridden by Dex treatment. Moreover, the findings in Figure 5c indicate that the presence of a site in either the promoter region from À940 to À764 (region I) or from À1081 to À940 (region II) is critical for optimal induction of txnip by Dex. To further identify which region is contributing to txnip gene induction by Dex, we cloned the txnip promoter fragment flanking regions I, II, and I þ II into pGL3P, which is a luciferase vector driven by the SV40 promoter, making the heterologous constructs pGL3P-1, pGL3P-2, and pGL3P-3, respectively (Figure 5d ). WEHI7.2 cells were transfected with each construct for 4 h and then treated with ethanol alone (vehicle control) or with 1 mM Dex for 12 h. Dex treatment induced pGL3P-2 and pGL3P-3 luciferase activity 4.9-and 5.6-fold, respectively ( Figure 5e ). These fold inductions by Dex are similar to the fold induction of pGL3B-1081 by Dex. In contrast, there was only 1.6-fold induction of pGL3P-1 by Dex and 1.3-fold induction of pGL3P by Dex, the latter serving as a vector control (Figure 5e ). These findings indicate that a site between À940 and À764 is responsible for induction of txnip by Dex.
Induction of the pGL3B-1081 and pGL3P-2 reporters was indeed mediated through the glucocorticoid receptor, since these reporters were not induced by Dex in cells lacking glucocorticoid receptors (Figure 6a ) and since the induction by Dex was blocked by the glucocorticoid receptor antagonist RU486 (Figure 6b ). Glucocorticoid receptor-mediated activation of gene transcription can be through a simple Figure 4 Activation of the txnip promoter by Dex. WEHI7.2 cells were transfected with 6 mg of pGL3B (a promoter-less firefly luciferase reporter), pGL3P (a reporter in which firefly luciferase expression is under control of a SV40 promoter), or pGL3B-1081 (a reporter in which firefly luciferase expression is under control of the txnip promoter region flanking 1 081 base pairs upstream from and 27 base pairs downstream from the transcription start site). Humanized Renilla luciferase (2 mg) reporter pRL-TK (Promega) was cotransfected as an internal control. Cells were cultured in the transfection medium for 4 h, and then additional DMEM medium was added with or without treatment for 12 h. (a) Luminescence was measured 16 h after transfection without Dex treatment. Firefly luciferase activity was normalized to the Renilla luciferase activity of each sample and results shown are the average of three independent transfections7s.e. (b) Cells were transfected as in panel a and 4 h after transfection, cells were treated with medium containing ethanol vehicle or Dex at either 10, 100, or 1000 nM for 12 h. Luminescence was measured and fold-induction was obtained by normalizing the relative luciferase activity of Dex-treated cells to the relative luciferase activity in vehicle-treated cells. Results represent mean7s.e. for three independent experiments. txnip induction by dexamethasone Z Wang et al glucocorticoid-responsive element (GRE) which has been defined as a pentadecameric imperfect palindrome, GGTACAnnnTGTTCT, in which the 3 0 half is most conserved (Nordeen et al., 1990; Truss et al., 1990; Cairns et al., 1991) . Although the program TFSEARCH did not detect a GRE in the txnip promoter, visual inspection of the promoter region from À940 to À764 identified a putative GRE (Figure 6c ). There are reports of GRE's located more than 1000 bp upstream of the transcriptional start site (reviewed in Schoneveld et al., 2004) . Therefore, to confirm that this putative GRE contributed to the induction of txnip by Dex, sitedirected mutagenesis was carried out to mutate two nucleotides in the 3 0 half of the putative GRE (Mut1 and Mut2) in both the pGL3B-1081 and pGL3P-2 reporter constructs (Figure 6c ). Transient transfection assays showed that both of these mutations markedly reduced the Dex-induced transcriptional activation of either pGL3B-1081 (Figure 6d ) or pGL3P-2 (Figure 6e ), indicating that the putative GRE indeed contributes to the induction of txnip by Dex. In summary, these findings indicate that the induction of txnip by Dex is a primary transcriptional event mediated by the glucocorticoid receptor.
Dex treatment elicits similar dose-dependent increases in apoptosis and txnip expression To investigate the potential involvement of txnip induction in apoptosis, WEHI7.2 cells were treated with 1-1000 nM Dex for 36 h, at which point apoptosis and txnip levels were measured. The percentage of cells undergoing apoptosis was determined by flow cytometry of propidium iodide stained cells to measure the sub-G 1 DNA peak characteristic of apoptotic cells. In parallel, the expression of txnip mRNA was measured by Northern blot analysis. Txnip was significantly induced only by concentrations of Dex sufficient to induce apoptosis (Figure 7a and b) . Thus, there appears to be a close correlation between induction of txnip and induction of apoptosis following Dex treatment.
Expression of txnip induces apoptosis in WEHI7.2 cells Next, we sought to determine whether the induction of txnip by Dex is alone capable of inducing a death signal. An expression vector encoding TXNIP fused to the C-terminus of enhanced GFP was transiently expressed in WEHI7.2 cells. DNA content and GFP-TXNIP expression were simultaneously measured by flow cytometry 18 h after transfection. DNA fragmentation (sub G 1 DNA content) indicative of apoptosis was detected in 15.4% of cells expressing GFP-TXNIP, whereas DNA fragmentation was detected in only 7.5% of the TXNIP negative cells within the same transfected cell population (n ¼ 5, P ¼ 0.018) (Figure 8 ). Increased apoptosis was not detected in control cells expressing GFP alone. These findings indicate that expression of txnip alone is sufficient to induce apoptosis.
Repression of endogenous txnip reduces sensitivity to Dex-induced apoptosis To investigate the involvement of endogenous txnip in apoptosis induction by Dex, RNA interference was used to repress txnip induction. Because of the low transfection efficiency of WEHI7.2 cells, stable populations of WEHI7.2 cells expressing an antibiotic selectable RNA interference vector were used. This approach has the added advantage that the time required for stable selection allows for turnover of protein synthesized prior the reduction of txnip, and the reduction of txnip mRNA likely will reflect a genuine decrease in TXNIP protein. Txnip mRNA levels were measured in cells expressing control siRNA and txnip siRNA. In this vector system, expression of short hairpin RNAs homologous to either the txnip open reading frame or a control gene encoding GFP were driven by the U6 RNA polymerase III promoter. In preliminary studies, three different txnip siRNA vectors were tested for their ability to repress expression of a murine GFP-TXNIP fusion protein driven by a CMV promoter. The most effective siRNA vector in this assay was chosen for use Figure 6 Identification of a putative GRE in the txnip promoter. (a) There was no Dex-induced luciferase reporter activity following treatment with 1 mM Dex for 12 h when S49 7R cells, which lack functional glucocorticoid receptors, were transfected with each luciferase reporter construct. (b) RU486 blocked Dex-induced luciferase reporter activity. WEHI7.2 cells were transfected and treated with ethanol vehicle control, 100 nM Dex, 5 mg/ml RU486 or 100 nM Dex þ 5 mg/ml RU486. Fold-induction was obtained by normalizing the relative luciferase activity of treated cells to the relative luciferase activity in vehicle-treated cells. Results are the mean7standard error (s.e.) for three independent experiments. (c) Sequences of the consensus GRE, putative GRE in the txnip promoter and its mutant constructs. (d) Mutation of the putative GRE in the pGL3B-1081 reporter diminished Dex-induced luciferase activity. (e) Mutation of the putative GRE in the pGL3P-2 reporter also diminished Dex-induced luciferase activity. WEHI7.2 cells were transfected and treated in the presence or absence of Dex as described in Figure 5 . Results are the mean7s.e. of four independent experiments. txnip induction by dexamethasone Z Wang et al in developing txnip siRNA stable clones. Northern blot analysis was used to measure the efficacy of txnip repression in representative clones from WEHI7.2 cells stably expressing either the txnip siRNA or control siRNA vector after 36 h of treatment with 1 mM Dex. As shown in Figure 9a and b, the txnip siRNA vector reduced expression of Dex-induced txnip by as much as 84% in stable clones. The cells expressing txnip siRNA were clearly more resistant to Dex-induced apoptosis than those expressing the control siRNA. After 36 h of treatment with 1 mM Dex, only 10.4% of the txnip siRNA expressing cells were apoptotic, whereas 21.8% of the control cells were apoptotic (Figure 9c , n ¼ 3, P ¼ 0.039). These findings support the hypothesis that txnip induction contributes to Dex-induced apoptosis.
Txnip is known to associate with reduced thioredoxin, thereby decreasing thioredoxin expression and inhibiting thioredoxin activity (Nishiyama et al., 1999; Junn et al., 2000) . Therefore, we measured thioredoxin activity in WEHI7.2 cells 36 h after Dex addition and found it to be significantly reduced compared to vehicletreated control cells (Figure 10) . Thus, an alteration in cellular redox may be one potential mechanism by which txnip induction contributes to Dex-induced apoptosis (see Discussion).
Discussion
We discovered through oligonucleotide microarray analysis that Dex treatment increases txnip mRNA levels in primary T cells and T-cell lines. This finding was initially obscured because probes corresponding to txnip were among 2611 defective probes present in the early batch of MG-U74A(v2) GeneChips used in our expression profiling of the S49.A2 cell line, but the induction was subsequently revealed using corrected probe sets. Northern analysis confirmed that expression of the txnip gene was induced by Dex not only in primary T cells and two murine T-cell lymphoma cell lines, but also in the CEM-C7-14 cells derived from human childhood T-cell acute lymphocytic leukemia. Using bioinformatics analysis of the published microarray data from other laboratories, we predict that txnip is not only induced by Dex in T cells, but also in multiple myeloma cells and 697 pre-B leukemic cells (Chauhan et al., 2002; Planey et al., 2003; Webb et al., 2003) .
The induction of txnip mRNA by Dex was mediated through the glucocorticoid receptor and was blocked by the glucocorticoid antagonist RU486. Furthermore, the increase in levels of txnip mRNA following Dex treatment was blocked by actinomycin D, but not by cycloheximide. These findings suggest that txnip may be a transcriptional target of the glucocorticoid receptor. txnip induction by dexamethasone Z Wang et al Consistent with this prediction, we identified a functional GRE in the txnip gene by deletion and mutation analysis of the txnip promoter. To the best of our knowledge, we are the first to demonstrate that txnip is a novel primary glucocorticoid receptor target gene.
The glucocorticoid receptor not only activates gene transcription by direct binding to the simple GRE, but also through interaction with transcription factors that bind to adjacent promoter regions (Schoneveld et al., 2004) . Thus, it is possible that induction of txnip transcription by Dex may also involve additional transcription factors. This notion is supported by evidence that the region from À1081 to À940 significantly enhanced luciferase activity from 2.8-fold by Dex with the pGL3B-940 reporter to 5.8 fold with the pGL3B-1081 reporter. Using TFSEARCH we found putative sites for the transcription factors Oct-1 and Ets within the region from À1081 to À940.
Transcriptional synergism between the glucocorticoid receptor and octamer transcription factor 1 (Oct-1) was reported in the induction of mouse mammary tumor virus transcription (Prefontaine et al., 1998) . Similarly, transcriptional synergism between the glucocorticoid receptor and Ets2 was involved in Dex-mediated transcriptional activation of the cytochrome P-450c27 promoter (Mullick et al., 2001) . Whether either Oct-1 or Ets has synergism with the glucocorticoid receptor in mediating Dex-induced txnip transcriptional activation is currently under investigation.
Txnip was originally isolated and identified as a gene upregulated by 1a, 25-dihydroxyvitamin D3 in HL-60 cells. Hence, it is also referred to as VDUP1 (Vitamin D upregulated protein-1) (Chen and DeLuca, 1994) . Txnip is also induced by apoptosis-inducing stress stimuli, including hydrogen peroxide, heat shock, reduction of extracellular potassium, nerve growth factor withdrawal, serum starvation, transforming growth factor b, and the histone deacetylase inhibitor suberoylanilide hydroxamic acid (Junn et al., 2000; Saitoh et al., 2001; Butler et al., 2002; Han et al., 2003) . Though the mechanism of induction is largely unknown, it was suggested that a NF-Y binding site is required for txnip induction by suberoylanilide hydroxamic acid (Butler et al., 2002) and that heat shock factor is an important transcription factor involved in upregulation of txnip expression following cellular stress following serum deprivation (Kim et al., 2004) . Most recently, it has been reported that a carbohydrate response element in the human txnip is necessary for glucose-induced txnip expression (Minn et al., 2005) .
Txnip is known to associate with reduced thioredoxin, thereby decreasing thioredoxin expression and inhibiting thioredoxin activity (Nishiyama et al., 1999; Junn et al., 2000) . Thioredoxin, a highly conserved oxygen radical scavenger, is one of the major prosurvival thiol reducing systems in cells (Nishinaka et al., 2001 ; txnip induction by dexamethasone Z Wang et al Powis and Montfort, 2001) . Interestingly, decreased thioredoxin activity has been suspected of playing a role in Dex-induced apoptosis, since Dex treatment decreases thioredoxin levels and increases oxidative damage in primary thymocytes and lymphoma cell lines (Tome et al., 2001) . Furthermore, overexpression of thioredox in WEHI7.2 lymphoma cells inhibits Dexinduced apoptosis (Baker et al., 1997) and treatment of thymocytes with antioxidants or culturing thymocytes under hypoxic conditions protects against Dex-induced apoptosis (Torres-Roca et al., 2000; Tonomura et al., 2003) . What has been missing is a link between glucocorticoid receptor-mediated gene transcription during the initiation stage of Dex-induced apoptosis and downstream effects on thioredoxin levels and oxygen radical formation. The induction of txnip by Dex may indeed be this missing link. Consistent with this hypothesis, we detected reduced thioredoxin activity and elevated reactive oxygen species in WEHI7.2 cells 36 h after treatment with Dex ( Figure 10 ). Indeed, data presented here reveal a close correlation between induction of txnip and induction of apoptosis following Dex treatment. Also, overexpression of TXNIP was sufficient to induce apoptosis. Furthermore, the ability of Dex to induce apoptosis was inhibited when txnip expression was repressed by siRNA. TXNIP by itself induced apoptosis and the ability of repression of txnip expression by siRNA strong inhibited Dex-induced apoptosis. These findings support the hypothesis that txnip induction plays an important role in Dex-induced apoptosis. In summary, through microarray analysis, we have identified at least four apoptosis-related genes induced by Dex in glucocortiocid-treated lymphocytes. Dig2 is a stress response gene, whose expression protects against glucocorticoid-induced apoptosis (Wang et al., 2003b) . Bim is a proapoptotic member of the Bcl-2 family (Wang et al., 2003a) . Tdag8 is a G protein-coupled receptor whose expression and activation enhances glucocorticoid-induced apoptosis (Malone et al., 2004) . Now, in this report, we show that txnip is a primary target gene of the glucocorticoid receptor and that its expression can mediate apoptosis. One of the next challenges will be to determine if these Dex-induced genes contribute independently to Dex-induced apoptosis, or if their regulation and/or functions are interdependent.
Materials and methods
Cell culture WEHI7.2 and S49.A2 murine T-cell lymphoma lines were gifts of Drs Diane Dowd (Case Western Reserve University) and Roger Miesfeld (University of Arizona), respectively. WEHI7.2 and S49.A2 cells were cultured in Dulbecco's modified Eagle's medium (DMEM), supplemented with 2 mM L-glutamine, 10% heat-inactivated bovine calf serum (HyClone), 12.5 U/ml penicillin, and 12.5 mg/ml streptomycin (Invitrogen). WEHI7.2 and S49.A2 cultures were seeded at a density of 1 Â 10 5 cells/ml and grown in a humidified 7% CO 2 incubator at 371C. The CEM-C7-14 human T-cell acute lymphocytic leukemia cell line was a gift of Dr EB Thompson (University of Texas Medical Branch) . CEM cells were cultured in RPMI 1640 medium supplemented with 2 mM Lglutamine, 10% heat-inactivated bovine calf serum, 12.5 U/ml penicillin, and 12.5 mg/ml streptomycin. CEM cultures were seeded at 2 Â 10 5 cells/ml and grown in a humidified 5% CO 2 incubator at 371C. Cell viability was monitored by trypan blue dye staining.
Thymus isolation C57BL/6J mice (Jackson Laboratory) were sacrificed by CO 2 asphyxiation. Thymus glands were removed, rinsed in ice-cold growth medium (DMEM supplemented with 10% fetal bovine serum, 2 mM L-glutamine, 12.5 U/ml penicillin, and 12.5 mg/ml streptomycin), and then dispersed through a steel wire mesh into 5 ml fresh, cold growth medium per thymus. The suspension of thymocytes was filtered through a tube with Cell-Strainer Cap (Becton Dickinson Labware) to remove connective tissue. Thymocytes were diluted to 2-3 Â 10 6 cells/ ml in warm growth medium, treated with 1 mM Dex or ethanol vehicle control, and grown in a humidified 7% CO 2 atmosphere at 371C.
Oligonucleotide array expression analysis
Gene expression analysis using Affymetrix MG-U74A(v2) GeneChips was performed as previouly described (Wang et al., 2003a, b) . Briefly, total RNA was purified from S49.A2 and WEHI7.2 cells treated with or without 1 mM Dex for 6, 12, 18, and 24 h or isolated from primary thymocytes treated with 1 mM Dex for 2 and 12 h. To compensate for gene expression changes occurring in the control cultures over time, each treated sample was compared with a control sample that was split and harvested in parallel with the treated population. Expression profiles of both Dex-treated and control populations at each time point were determined using Affymetrix MG-U74A(v2) GeneChips. Comparative analysis of treatment and control samples was performed with the Affymetrix statistical algorithm using default parameters. Metric files from expression and comparison analyses were exported to Microsoft Access XP for further filtering and analysis. Genes considered 'significantly changed' were those that possessed a reliably detectable signal (absolute call a 'absent' and signal X500 in treatment or control samples for inductions or repressions, respectively) and were determined by the statistical algorithm to be changed twofold or greater (change call a 'no change' and signal X500 in treatment or control samples for inductions or repressions, respectively). To increase stringency, genes meeting the above criteria were filtered further to include only those that were changed in the same direction (change call a 'no change') in at least one adjacent time point regardless of magnitude.
Northern blot analysis
Northern blot analysis was performed as previously described (Wang et al., 2003a, b) , with the following modifications. In all, 10 mg of total RNA (2.5 mg for the sample from primary thymocytes and 2.0 mg for the samples from siRNA clones) was used for Northern blot analysis. The 32 P-labeled txnip probe was prepared from a full-length txnip cDNA purchased from ATCC.
Construction of txnip promoter luciferase reporters
The mouse txnip promoter region between 1081 base pair upstream and 47 base pair downstream of the transcription start site was amplified by PCR from mouse genomic DNA using primers incorporating a HindIII site, txnip induction by dexamethasone Z Wang et al 5 0 agctaagctt-GGTTAGGGACATGCATTTCA 3 0 (Forward primer) and 5 0 agctaagctt-CGAGACCAGAGGAGGAGAGT 3 0 (Reverse primer). The PCR product was sequenced and cloned into the pGL3-basic vector (pGL3B) from Promega to generate the txnip luciferase reporter pGL3B-1081. The 5 0 txnip deletion mutants were generated by PCR using the following forward primers: 5 0 acgtgctagc-TGTCCACC TCTTGTTTCCTG 3 0 , 5 0 acgtgctagc-TCCGCTCCAGAGAA CAGCCT 3 0 , 5 0 acgtctagc-CATCCTGGAGTATCCTCGGT 3 0 , 5 0 acgtgctagc-GCTCAGGCGAGTCATGAA 3 0 , 5 0 acgtgc tagc-GCCTCGCTGATTGGTTGG 3 0 and the reverse primer: 5 0 TACCAACAGTACCGGAATGC 3 0 , with pGL3B-1081 as the template. The resulting PCR fragments were digested with HindIII and NheI, and cloned into the larger fragment of pGL3B-1081, which was digested with HindIII and NheI. To generate three heterologous reporter constructs (pGL3P-1, pGL3P-2, and pGL3P-3), the potential Dex responsive regions in the txnip promoter were amplified by PCR using pGL3B-1081 as the template, and cloned into the pGL3-Promoter vector (pGL3P) from Promega. The following primers were used for the PCR amplification: 5 0 acgtgctagc-GCCTCG CTGATTGGTTGG 3 0 , 5 0 acgtgctagc-TGTCCACCTCTTG TTTCCTG 3 0 , 5 0 atcgctcga-GAAAGAACCTCACTCCTTA CTTTG 3 0 and 5 0 ctagctcga-GAGCAGTAAGGGAGTGTC CAC 3 0 . Mutations were generated in the putative GRE contained in the pGL3B-1081 and pGL3P-2 reporter constructs using the QuikChange II site-directed mutagenesis kit (Stratagene). Either 5 0 AGGGAACATATACAAAAGCTTCCCCAACTT CACAGGT 3 0 or 5 0 AGGGAACATATACAAAAAGATCC CCAACTTCACAGGT 3 0 was used to mutate the putative GRE 3 0 site from TGTTCC to GCTTCC or AGATCC respectively. The mutation in each plasmid was verified by sequence analysis.
Transient transfection experiments WEHI7.2 cells were transfected with the various txnip reporter constructs in Opti-Mem I reduced serum medium using the DMRIE-C reagent (Invitrogen) according to the manufacturer's instructions. Briefly, 6 ml of DMRIE-C reagent was added to each well of six-well plates with 500 ml of Opti-Mem I reduced serum medium. For each well, 6 mg of reporter construct and 2 mg of internal control plasmid pRL-TK were diluted into 100 ml of Opti-Mem I, added to each well, swirled to mix and incubated at room temperature for 30 min. While incubating, the required amount of WEHI7.2 cells (2 million cells/well) were pelleted and resuspended to 10million cells/ml in Opti-Mem I. At the end of the incubation, 200 ml of cell suspension was added to each well and incubated for 4 h at 371C. At 4 h after transfection, complete DMEM medium was added in the presence of 1 mM Dex or ethanol as the vehicle control. Cells were harvested 12 h after Dex treatment and firefly and renilla luciferase activities were determined using the Dual Luciferase Assay Kit (Promega).
Apoptosis assay
The dye Hoechst 33342 (Molecular Probes) was used to measure cellular DNA content in living cells. Culture samples containing 2 Â 10 6 cells were collected by centrifugation at 200 Â g for 5 min, and resuspended in 1 ml phosphate-buffered saline. Hoechst 33342 was added to a final concentration of 5 mg/ml and incubated at 371C for 15-30 min. Fluorescence was measured using a BD LSR I flow cytometer (BD Science). Data analysis was performed using WinList 3D version 5.0 (Verity Software House). Propidium iodide (Molecular Probes) was used to measure the cellular DNA content of fixed cells as described previously (Malone et al., 2004) .
GFP-TXNIP expression
The GFP-TXNIP expression vector was constructed by fusing the N-terminus of mouse txnip in frame to a cDNA encoding enhanced GFP, located in pEmd-C1 as the parental vector (Packard Instrument Co., Meriden, CT). WEHI7.2 cells were transfected with either GFP-TXNIP or empty pEmd-C1 by electroporation. Ten million viable cells were collected by centrifugation at 200 g for 5 min and then suspended in 200 ml prewarmed Opti-Mem I reduced serum medium. Cell suspensions were mixed with 50 mg of either GFP-TXNIP or pEmd-C1 and transferred to a 0.2-cm gap Gene Pulser cuvette (BioRad). The cells were electroporated with a Bio-Rad GenePulser Xcell using a 110 v square wave with a 10 ms pulse, then transferred immediately to 30 ml of warm growth medium, and incubated for 18 h. GFP expression and apoptosis were measured on a BD LSR I flow cytometer (BD Science). Data analysis was performed using WinList 3D version 5.0 (Verity Software House).
RNA interference
Hairpin oligonucleotides containing the target sequence (5 0 GTCTCTGCTCGAATTGACA 3 0 ), homologous to the murine txnip mRNA, flanked by HindIII and BamHI compatible overhangs were synthesized by Qiagen. Sense and antisense oligonucleotides were annealed then ligated for 16 h at 141C into HindIII and BamHI doubled-digested pSilencer2.1-U6 hygro (Ambion Inc.) using 400 U of T4 ligase (New England Biolabs). Ligase reaction products were cloned into chemically competent DH5a (Invitogen). Proper insertion of the txnip RNAi hairpin oligonucleotides into the pSilencer vector was confirmed by sequencing (Cleveland Genomics). A pSilencer-GFP plasmid containing the RNAi hairpin oligonucleotide homologous to 21 base pairs of the coding region of enhanced GFP was used as a negative control. The pSilencer-TXNIP or pSilencer-GFP plasmids were transfected into WEHI7.2 cells by electroporation as described above. Electroporated cells were seeded into a T-75 flask containing 30 ml of fresh growth medium. At 24 h after electroporation, 10 million WEHI7.2 cells were placed on soft agar plates containing a final concentration of 1 mg/ml hygromycin (Invitrogen). Stable clones were picked after one-week in culture. The ability of pSilencer-TXNIP to repress txnip mRNA was confirmed by Northern blotting of stable clones treated with 1 mM Dex for 36 h and apoptosis was measured by flow cytometry following propidium iodide-staining.
Thioredoxin activity assay TRX activity was measured using the insulin disulfide reduction assay as described (Wang et al., 2002; Yamawaki et al., 2005) with a slight modification. Cell extracts (20 mg, 68 ml) were incubated at 371C for 20 min with 2 ml of reducing buffer composed of 50 mM HEPES (pH 7.6), 1 mM EDTA, 1 mg/ml BSA, and 2 mM DTT. Then 40 ml of reaction buffer containing 200 ml of 1M HEPES (pH 7.6), 16 ml of 0.5 M EDTA, 80 ml of NADPH (20 mg/ml), and 500 ml of insulin (10 mg/ml) was added. The reaction was started by the addition of 10 ml of bovine TRX reductase (American Diagnostica Inc.) and continued for 20 min at 371C. The reaction was terminated by the addition of 500 ml of 10 M guanidine-HCl, and 1.7 mM DTNB (3-carboxy-4-nitrophenyl disulfide), and the absorbance at 405 nm was measured spectroscopically.
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